nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel prognostic model of methylation-associated genes in acute myeloid leukemia
|
Chen, Meiyu |
|
|
25 |
6 |
p. 1719-1728 |
artikel |
2 |
A novel regulator in cancer initiation and progression: long noncoding RNA SHNG9
|
Zhao, Mingxing |
|
|
25 |
6 |
p. 1512-1521 |
artikel |
3 |
Bcl-2 pathway inhibition in solid tumors: a review of clinical trials
|
Ploumaki, Ioanna |
|
|
25 |
6 |
p. 1554-1578 |
artikel |
4 |
Bioinformatic analysis of single-cell RNA sequencing dataset dissects cellular heterogeneity of triple-negative breast cancer in transcriptional profile, splicing event and crosstalk network
|
Qiu, Jin |
|
|
25 |
6 |
p. 1856-1868 |
artikel |
5 |
Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α
|
Dai, Jie-min |
|
|
25 |
6 |
p. 1606-1616 |
artikel |
6 |
CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p
|
Lu, Qing |
|
|
25 |
6 |
p. 1690-1701 |
artikel |
7 |
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China
|
Lin, Zhijuan |
|
|
25 |
6 |
p. 1821-1829 |
artikel |
8 |
Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML
|
Wang, Jun-Dan |
|
|
25 |
6 |
p. 1805-1820 |
artikel |
9 |
Epigenetic inhibition of lncRNA GMDS-AS1 by methyltransferase ESET promoted cell viability and metastasis of hepatocellular carcinoma
|
Huang, Junling |
|
|
25 |
6 |
p. 1793-1804 |
artikel |
10 |
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma
|
Rao, Wen |
|
|
25 |
6 |
p. 1767-1778 |
artikel |
11 |
Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review
|
Khorshid Shamshiri, Asma |
|
|
25 |
6 |
p. 1729-1747 |
artikel |
12 |
HIF-1α contributes to metastasis in choriocarcinoma by regulating DEC1 expression
|
Xu, Yihui |
|
|
25 |
6 |
p. 1641-1649 |
artikel |
13 |
Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview
|
Charidemou, Evelina |
|
|
25 |
6 |
p. 1594-1605 |
artikel |
14 |
HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma
|
Li, Yiqiu |
|
|
25 |
6 |
p. 1682-1689 |
artikel |
15 |
Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma
|
Chen, Ran |
|
|
25 |
6 |
p. 1617-1628 |
artikel |
16 |
Lactobacillus for ribosome peptide editing cancer
|
Yue, Shousong |
|
|
25 |
6 |
p. 1522-1544 |
artikel |
17 |
LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p
|
Buranjiang, Gulimire |
|
|
25 |
6 |
p. 1650-1660 |
artikel |
18 |
Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq
|
Zhang, Yang |
|
|
25 |
6 |
p. 1844-1855 |
artikel |
19 |
Non-coding RNAs as potential biomarkers of gallbladder cancer
|
Lv, Yan |
|
|
25 |
6 |
p. 1489-1511 |
artikel |
20 |
Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study
|
Liang, Wenjing |
|
|
25 |
6 |
p. 1779-1792 |
artikel |
21 |
Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients
|
Fu, Dong |
|
|
25 |
6 |
p. 1710-1718 |
artikel |
22 |
Prediction model of colorectal cancer (CRC) lymph node metastasis based on intestinal bacteria
|
Yinhang, Wu |
|
|
25 |
6 |
p. 1661-1672 |
artikel |
23 |
Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways
|
Zhang, Yi-Dan |
|
|
25 |
6 |
p. 1629-1640 |
artikel |
24 |
Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness
|
Pérez-Montero, Héctor |
|
|
25 |
6 |
p. 1756-1766 |
artikel |
25 |
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
|
Wang, Wei |
|
|
25 |
6 |
p. 1673-1681 |
artikel |
26 |
The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis
|
Sun, Yalan |
|
|
25 |
6 |
p. 1830-1843 |
artikel |
27 |
Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase
|
Rahimi Lifshagerd, Marzieh |
|
|
25 |
6 |
p. 1702-1709 |
artikel |
28 |
The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook
|
Song, Xiaolu |
|
|
25 |
6 |
p. 1545-1553 |
artikel |
29 |
Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer
|
Zhang, Weiqian |
|
|
25 |
6 |
p. 1579-1593 |
artikel |
30 |
Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
|
Zhang, Yaowen |
|
|
25 |
6 |
p. 1748-1755 |
artikel |